Mechanisms and Management of Cardiovascular and Metabolic Complications of HIV/AIDS (R01)

The summary for the Mechanisms and Management of Cardiovascular and Metabolic Complications of HIV/AIDS (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Mechanisms and Management of Cardiovascular and Metabolic Complications of HIV/AIDS (R01): -Purpose: The purpose of this FOA is to foster collaborative research to elucidate the underlying mechanisms of metabolic and anthropometric abnormalities seen in HIV infection and highly active antiretroviral therapy (HAART) and their relationship to cardiovascular disease (CVD) risk; to evaluate novel and existing biomarkers and imaging modalities in the assessment of coronary artery disease and risk in HIV patients; and to identify treatment strategies and interventional approaches to reduce cardiovascular risk while optimizing the medical management of HIV infection. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. The NHLBI intends to commit $8 million in FY2008 to fund approximately 8 applications for up to 5 years for each application (1 Data Coordinating Center and 6-7 Clinical Research Sites) submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Federal Grant Title:	Mechanisms and Management of Cardiovascular and Metabolic Complications of HIV/AIDS (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-08-003
Type of Funding:	Grant
CFDA Numbers:	93.837
CFDA Descriptions:	Heart and Vascular Diseases Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Feb 22, 2008
Posted Date:	Jan 15, 2008
Creation Date:	Jan 18, 2008
Archive Date:	Apr 25, 2008
Total Program Funding:	$8,000,000
Maximum Federal Grant Award:	$650,000
Minimum Federal Grant Award:
Expected Number of Awards:	8
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Independent school districts For profit organizations other than small businesses Private institutions of higher education State governments County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...; • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...; • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...; • ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial No...; • The Relationship Between Hypertension and Inflammation; • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...; • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...